- Supported exchanges /
- AU /
- IVX.AU
Invion Ltd (IVX AU) stock market data APIs
Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, and solid cancers, such as lung, ovarian, anogenital, and glioblastoma multiforme cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Invion Ltd Financial Data Overview
| 0.003 | |
| 0.003 | |
| - | |
| 0.003 | |
| 0.003 | |
| 0.002-0.008 | |
| 20 300 K | |
| 6 767 M | |
| 3 694 K | |
| 1.125 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Invion Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 694 K
- EBITDA -4 861 189
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Invion Ltd Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Invion Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
